Clare Cutland to Infant
This is a "connection" page, showing publications Clare Cutland has written about Infant.
Connection Strength
1,792
-
Association of Group B Streptococcus (GBS) Serum Serotype-Specific Anticapsular Immunoglobulin G Concentration and Risk Reduction for Invasive GBS Disease in South African Infants: An Observational Birth-Cohort, Matched Case-Control Study. Clin Infect Dis. 2021 09 07; 73(5):e1170-e1180.
Score: 0,123
-
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study. Vaccine. 2018 03 27; 36(14):1908-1916.
Score: 0,096
-
Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country. Vaccine. 2015 Nov 25; 33(47):6406-12.
Score: 0,081
-
Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1). Emerg Infect Dis. 2015 Apr; 21(4):638-45.
Score: 0,078
-
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study. Expert Rev Vaccines. 2025 Dec; 24(1):121-127.
Score: 0,039
-
Burden of Lassa fever disease in pregnant women and children and options for prevention. Vaccine. 2025 Jan 01; 43(Pt 1):126479.
Score: 0,038
-
High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response. Nat Med. 2024 May; 30(5):1384-1394.
Score: 0,037
-
Importance of nosocomial respiratory syncytial virus infections in an African setting. Trop Med Int Health. 2004 Apr; 9(4):491-8.
Score: 0,037
-
Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial. Lancet Child Adolesc Health. 2023 05; 7(5):326-335.
Score: 0,034
-
In-hospital mortality risk stratification in children aged under 5 years with pneumonia with or without pulse oximetry: A secondary analysis of the Pneumonia REsearch Partnership to Assess WHO REcommendations (PREPARE) dataset. Int J Infect Dis. 2023 Apr; 129:240-250.
Score: 0,034
-
Assembling a global database of child pneumonia studies to inform WHO pneumonia management algorithm: Methodology and applications. J Glob Health. 2022 Dec 29; 12:04075.
Score: 0,034
-
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. Lancet Infect Dis. 2023 01; 23(1):e2-e21.
Score: 0,033
-
Derivation and validation of a novel risk assessment tool to identify children aged 2-59 months at risk of hospitalised pneumonia-related mortality in 20 countries. BMJ Glob Health. 2022 Apr; 7(4).
Score: 0,032
-
Incidence of febrile seizures and associated factors in children in Soweto, South Africa. S Afr Med J. 2021 Aug 02; 111(8):796-802.
Score: 0,030
-
Malaria is a cause of iron deficiency in African children. Nat Med. 2021 04; 27(4):653-658.
Score: 0,030
-
Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV. mBio. 2021 01 08; 12(1).
Score: 0,029
-
Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials. Expert Rev Vaccines. 2020 12; 19(12):1177-1189.
Score: 0,029
-
Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South Africa. Vaccine. 2020 09 22; 38(41):6478-6483.
Score: 0,029
-
Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial. Lancet Infect Dis. 2020 12; 20(12):1426-1436.
Score: 0,029
-
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. N Engl J Med. 2020 07 30; 383(5):426-439.
Score: 0,028
-
Influenza or Meningococcal Immunization During Pregnancy and Mortality in Women and Infants: A Pooled Analysis of Randomized Controlled Trials. Pediatr Infect Dis J. 2020 07; 39(7):641-644.
Score: 0,028
-
Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials. Lancet Respir Med. 2020 06; 8(6):597-608.
Score: 0,028
-
Estimating the burden of iron deficiency among African children. BMC Med. 2020 02 27; 18(1):31.
Score: 0,028
-
Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa. Vaccine. 2020 02 28; 38(10):2350-2360.
Score: 0,027
-
Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial. Lancet HIV. 2020 02; 7(2):e91-e103.
Score: 0,027
-
Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)-Unexposed and HIV-Exposed, Uninfected South African Children. J Infect Dis. 2019 09 26; 220(9):1529-1538.
Score: 0,027
-
The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia. Sci Adv. 2019 09; 5(9):eaaw0109.
Score: 0,027
-
HIV-Exposed Uninfected Infants Have Increased Regulatory T Cells That Correlate With Decreased T Cell Function. Front Immunol. 2019; 10:595.
Score: 0,026
-
Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres. Vaccine. 2019 03 22; 37(13):1876-1884.
Score: 0,025
-
The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs. mSphere. 2018 11 07; 3(6).
Score: 0,025
-
Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study. Clin Infect Dis. 2018 05 17; 66(11):1658-1665.
Score: 0,024
-
Influenza Vaccination during Pregnancy and Protection against Pertussis. N Engl J Med. 2018 03 29; 378(13):1257-1258.
Score: 0,024
-
Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy. Clin Infect Dis. 2017 Nov 13; 65(11):1897-1904.
Score: 0,024
-
Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S190-S199.
Score: 0,023
-
Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial. Clin Infect Dis. 2017 10 01; 65(7):1066-1071.
Score: 0,023
-
Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial. Expert Rev Vaccines. 2017 06; 16(6):641-656.
Score: 0,023
-
Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status. Medicine (Baltimore). 2017 Jan; 96(2):e5881.
Score: 0,022
-
Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. PLoS One. 2016; 11(12):e0169101.
Score: 0,022
-
Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother-Infant Dyads: A Longitudinal Cohort Study. Clin Infect Dis. 2016 Dec 01; 63(suppl 4):S174-S180.
Score: 0,022
-
Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy. Vaccine. 2016 12 01; 34(49):6007-6014.
Score: 0,022
-
Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 2016 12 01; 34(49):6047-6056.
Score: 0,022
-
Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2016 12 01; 34(49):6027-6037.
Score: 0,021
-
Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis. 2016 May; 16(5):546-555.
Score: 0,021
-
Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants. Vaccine. 2015 Nov 27; 33(48):6793-9.
Score: 0,020
-
Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants. Expert Rev Vaccines. 2015; 14(12):1651-60.
Score: 0,020
-
Bacterial and Respiratory Viral Interactions in the Etiology of Acute Otitis Media in HIV-infected and HIV-uninfected South African Children. Pediatr Infect Dis J. 2015 Jul; 34(7):753-60.
Score: 0,020
-
Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants. J Infect Dis. 2015 Dec 15; 212(12):1976-87.
Score: 0,020
-
Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLoS One. 2015; 10(4):e0123014.
Score: 0,020
-
Polyomaviruses-associated respiratory infections in HIV-infected and HIV-uninfected children. J Clin Virol. 2014 Dec; 61(4):571-8.
Score: 0,019
-
Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 04; 371(10):918-31.
Score: 0,019
-
Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants. Pediatr Infect Dis J. 2013 Aug; 32(8):889-97.
Score: 0,017
-
Acquisition of Streptococcus pneumoniae in pneumococcal conjugate vaccine-naïve South African children and their mothers. Pediatr Infect Dis J. 2013 May; 32(5):e192-205.
Score: 0,017
-
Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial. AIDS. 2013 Jan 28; 27(3):369-79.
Score: 0,017
-
Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa. J Med Microbiol. 2013 Feb; 62(Pt 2):249-253.
Score: 0,017
-
One-year post-primary antibody persistence and booster immune response to a DTaP-IPV//PRP~T vaccine (Pentaxim) given at 18 - 19 months of age in South African children primed at 6, 10 and 14 weeks of age with the same vaccine. S Afr Med J. 2011 Nov 28; 101(12):879-83.
Score: 0,016
-
Immunogenicity and safety of an investigational fully liquid hexavalent combination vaccine versus licensed combination vaccines at 6, 10, and 14 weeks of age in healthy South African infants. Pediatr Infect Dis J. 2011 Apr; 30(4):e68-74.
Score: 0,015
-
Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa. S Afr Med J. 2011 Feb; 101(2):126-31.
Score: 0,015
-
Seasonality, incidence, and repeat human metapneumovirus lower respiratory tract infections in an area with a high prevalence of human immunodeficiency virus type-1 infection. Pediatr Infect Dis J. 2007 Aug; 26(8):693-9.
Score: 0,012
-
Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine. 2007 Mar 22; 25(13):2451-7.
Score: 0,011
-
Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia. Pediatr Infect Dis J. 2006 Jan; 25(1):30-6.
Score: 0,010
-
Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers. Vaccine. 2006 Mar 20; 24(13):2432-9.
Score: 0,010
-
Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children. Vaccine. 2005 Dec 01; 23(48-49):5517-25.
Score: 0,010
-
Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J. 2005 May; 24(5):410-6.
Score: 0,010
-
The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis. 2005 May 15; 40(10):1511-8.
Score: 0,010
-
Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia. Clin Infect Dis. 2002 Nov 01; 35(9):1120-6.
Score: 0,008